Despite a low myotoxic profile, fluvastatin has been reported to activate the NLRP3 inflammasome and induce adipose tissue insulin resistance in obese animals at levels comparable to, or greater than lovastatin, atorvastatin, and simvastatin (16). Here, NLRP3 is linked to Insulin resistance.